Surrozen, Inc.

Surrozen, Inc. Stock Forecast & Price Prediction

Live Surrozen, Inc. Stock (SRZN) Price
$8.38

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$8.38

P/E Ratio

-0.47

Volume Traded Today

$10,188

Dividend

Dividends not available for SRZN

52 Week High/low

16.19/4.50

Surrozen, Inc. Market Cap

$30.1M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $SRZN ๐Ÿ›‘

Before you buy SRZN you'll want to see this list of ten stocks that have huge potential. Want to see if SRZN made the cut? Enter your email below

SRZN Summary

Based on ratings from 0 stock analysts, the Surrozen, Inc. stock price is expected to increase by 293.79% in 12 months. This is calculated by using the average 12-month stock price forecast for Surrozen, Inc.. The lowest target is $33 and the highest is $33. Please note analyst price targets are not guaranteed and could be missed completely.

SRZN Analyst Ratings

Surrozen, Inc. has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Surrozen, Inc. will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

SRZN stock forecast by analyst

These are the latest 20 analyst ratings of SRZN.

Analyst/Firm

Rating

Price Target

Change

Date

Eric Joseph
JP Morgan

Underweight


Downgrade

Nov 29, 2022
Yatin Suneja
Guggenheim

Neutral


Downgrade

Nov 18, 2022
Tazeen Ahmad
B of A Securities

Underperform

$1

Downgrade

Nov 17, 2022
Eric Joseph
JP Morgan

Neutral


Initiates

Oct 17, 2022
Tazeen Ahmad
B of A Securities

Neutral

$5

Downgrade

May 27, 2022

B of A Securities

Buy


Initiates

Oct 11, 2021

Guggenheim

Buy


Initiates

Sep 15, 2021

Stifel

Buy


Initiates

Sep 7, 2021

SRZN Company Information

  • Company Type: Clinical stage biotechnology company
  • Focus Area: Discovering and developing drug candidates to modulate the Wnt pathway for tissue repair
  • Product Type: Antibody-based therapeutics
  • Disease Areas: Targets diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system
  • Pipeline Products:
    • SZN-043: Hepatocyte-specific R-spondin mimetic bispecific fusion protein in Phase 1b clinical trial for severe liver diseases
    • SZN-413: Fzd4 targeted bi-specific antibody for retinal vascular diseases
  • Collaborations: Partnership with Boehringer Ingelheim International GmbH for research and commercialization of Fzd4 bi-specific antibodies
  • Location: Based in South San Francisco, California
SRZN
Surrozen, Inc. (SRZN)

When did it IPO

N/A

Staff Count

42

Country

United States

Sector/Industry

Healthcare/Biotechnology

CEO

Mr. Craig C. Parker M.B.A.

Market Cap

$30.1M

Surrozen, Inc. (SRZN) Financial Data

In 2023, SRZN generated $0 in revenue, which was a decrease of -100.00% from the previous year. This can be seen as a signal that SRZN's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$0

Revenue From 2021

$0

0.00 %
From Previous Year

Revenue From 2022

$12.5M

0.00 %
From Previous Year

Revenue From 2023

$0

-100.00 %
From Previous Year
  • Revenue TTM $0
  • Operating Margin TTM 0.0%
  • Gross profit TTM $0
  • Return on assets TTM -43.0%
  • Return on equity TTM -174.9%
  • Profit Margin 0.0%
  • Book Value Per Share 1.89%
  • Market capitalisation $30.1M
  • Revenue for 2021 $0
  • Revenue for 2022 $12.5M
  • Revenue for 2023 $0
  • EPS this year (TTM) $-22.49

Surrozen, Inc. (SRZN) Latest News

No news data available.

...

SRZN Frequently asked questions

The highest forecasted price for SRZN is $33 from at .

The lowest forecasted price for SRZN is $33 from from

The SRZN analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.